CG MedTech Co.,Ltd. (KOSDAQ:056090)
1,354.00
+2.00 (0.15%)
At close: Jun 5, 2026
CG MedTech Revenue
CG MedTech had revenue of 13.04B KRW in the quarter ending March 31, 2026, with 10.87% growth. This brings the company's revenue in the last twelve months to 48.51B, up 27.56% year-over-year. In the year 2025, CG MedTech had annual revenue of 47.23B with 36.43% growth.
Revenue (ttm)
48.51B
Revenue Growth
+27.56%
P/S Ratio
2.88
Revenue / Employee
404.28M
Employees
120
Market Cap
139.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.23B | 12.61B | 36.43% |
| Dec 31, 2024 | 34.62B | -345.79M | -0.99% |
| Dec 31, 2023 | 34.97B | -6.20B | -15.06% |
| Dec 31, 2022 | 41.17B | 3.11B | 8.18% |
| Dec 31, 2021 | 38.06B | 10.28B | 37.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 137.97B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 64.49B |
| OSTEONIC | 48.77B |
| DuChemBIO | 39.82B |
| Wonbiogen | 36.27B |
| SCL Science | 27.40B |
| MEDYSSEY Co.,Ltd | 10.60B |